If the child begins to squint: we control myopia and its progression

Author: M.V. Shevkolenko, Ph.D., expert in pediatric ophthalmology of the Kiev Department of Health


Myopia in the modern world is becoming an increasingly urgent medical and social problem due to the steady increase in the number of people with myopia, especially among children. At the same time, the number of children with complicated forms of myopia is significantly increasing.

Timely detection and adequate correction of myopia are necessary measures to curb the progression of the disease, prevent complications and disability. In case of complaints of visual impairment or in case of changes in the child’s behavior (coming close to the TV or squinting), an examination by a pediatric ophthalmologist is recommended. Correction of myopia in order to achieve the highest quality vision is preferable to prevent the progression of the disease. The vitamin and mineral complex SlezaVit® can be used in the complex management of patients with myopia to increase tolerance to visual stress and reduce the symptoms of asthenopia.

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

PROVE YOU ARE A MEDICAL PROFESSIONAL

Attention: This section is intended for healthcare professionals only. If you are not a medical professional, you can return to the main page by clicking the “No” option

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design